UPDATED EFFICACY AND SAFETY OF DABRAFENIB PLUS TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E-MUTATED HIGH-GRADE GLIOMA (HGG) AND LOW-GRADE GLIOMA (LGG)
 
UPDATED EFFICACY AND SAFETY OF DABRAFENIB PLUS TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E-MUTATED HIGH-GRADE GLIOMA (HGG) AND LOW-GRADE GLIOMA (LGG) 
 
Patrick Wen, Patrick Wen, Alexander Stein, Alexander Stein, Martin van den Bent, Martin van den Bent, Jacques De Greve, Jacques De Greve, Sascha Dietrich, Sascha Dietrich, Filip De Vos, Filip De Vos, Nikolas von Bubnoff, Nikolas von Bubnoff, Myra van Linde, Myra van Linde, Albert Lai, Albert Lai, Gerald Prager, Gerald Prager, Mario Campone, Mario Campone, Angelica Fasolo, Angelica Fasolo, Jose Lopez-Martin, Jose Lopez-Martin, Tae Min Kim, Tae Min Kim, Warren Mason, Warren Mason, Ralf-Dieter Hofheinz, Ralf-Dieter Hofheinz, Jean-Yves Blay, Jean-Yves Blay, Daniel Cho, Daniel Cho, Anas Gazzah, Anas Gazzah, Carlos Gomez-Roca, Carlos Gomez-Roca, Jeffrey Yachnin, Jeffrey Yachnin, Aislyn Boran, Aislyn Boran, Paul Burgess, Paul Burgess, Ilan Palanichamy, Ilan Palanichamy, Eduard Gasal, Eduard Gasal, Vivek Subbiah, Vivek Subbiah
 
Abstract 

not available